AI drug dis­cov­ery start­up goes pub­lic in Hong Kong, nab­bing $115M to build on phar­ma part­ner­ships

Chi­nese AI drug dis­cov­ery com­pa­ny XtalPi has land­ed on the Hong Kong stock ex­change af­ter near­ly $115 mil­lion ($896.13 mil­lion HKD) from an IPO. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.